Drug profile · INN
teduglutide
REVESTIVE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
teduglutide (REVESTIVE) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN teduglutide
Brand REVESTIVE
Route SUBCUTANEOUS
Formulation POWDER
ATC code A16AX08
Originator Lacuna Pharma Pty Ltd
Frequently asked questions
What is teduglutide?
teduglutide (REVESTIVE) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for teduglutide?
REVESTIVE is a marketed brand name for teduglutide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of teduglutide?
teduglutide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.